Gilead price target lifted to $158 by Truist Securities
Truist Securities raised its price target on Gilead Sciences to $158.00 from $150.00 and maintained a Buy rating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.